Skip to content

Comparison of the effect of laser and medicine in glaucoma

Comparison of the effect of antiglaucoma drugs with Selective Laser Trabeculoplasty (SLT) in patients with primary open angle glaucoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230330057786N1
Enrollment
60
Registered
2023-09-05
Start date
2023-09-23
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary open angle glaucoma. Open-angle glaucoma

Interventions

Intervention 1: Intervention group 1: The first intervention group: Selective Laser Trabeculoplasty group: a few mi

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 years Diagnosis of POAG (POAG is an optic neuropathy with increased intraocular pressure in which the angle of the anterior chamber of the eye is open and no secondary disease or cause can be found to justify optic nerve damage or increased intraocular pressure). Newly diagnosed patients and those who are currently receiving the standard first-line treatment, i.e. latanoprost eye drops, but their target IOP has not been achieved.

Exclusion criteria

Exclusion criteria: Secondary glaucoma diagnosis One eye patients (patients whose other eye is blind for any reason). Having very high IOP (above 30 mm Hg) Patients who have currently received the maximum tolerated medical treatment (Maximum Tolerated Medical Treatment), but despite the treatment, their IOP has not been controlled. History of laser trabeculoplasty or retina surgery History of cataract surgery in the last 3 months Active eye infection or inflammation Narrow eye angle Pregnant or lactating women Any eye disease that prevents accurate IOP measurement. Like a corneal scar Any unstable medical condition that prevents compliance with the scientific and ethical bases of the study protocol.

Design outcomes

Primary

MeasureTime frame
Percentage of eye pressure reduction in glaucoma patients. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month and 6 months after the start of the treatment. Method of measurement: Goldman tonometer.

Secondary

MeasureTime frame
Visual acuity. Timepoint: At the beginning of the study (before the start of the intervention) and 1 month and 6 months after the start of the treatment. Method of measurement: Snellen vision measurement chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Arish

Zahedan University of Medical Sciences

Arish.Mohammad@gmail.com+98 54 3322 4991

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026